Please find below the latest White Papers provided by agencies and companies within the healthcare and pharmaceutical industry. These are provided by external comoanies and are not approved of, checked or edited by PMLiVE or PMGroup Worldwide Ltd.
January 19, 2023 | White Papers and Resources |
How does Pharma-HCP engagement need to evolve in today’s digital landscape?
Brought to you by EPG Health
January 16, 2023 | White Papers and Resources |
Our 2022 Christmas campaign saw Santa’s agency elves creating tailored materials for patients. But were the examples guided by the principles of health literacy? Were …
Brought to you by Cuttsy + Cuttsy
January 13, 2023 | White Papers and Resources |
Supporting the launch of a global vaccine with a programme of market research and strategic insights
Brought to you by Inizio
January 13, 2023 | White Papers and Resources |
Watch to find out how a combination of virtual patients and artificial intelligence can help you to better understand physicians’ decision making processes.
Brought to you by Inizio
January 9, 2023 | White Papers and Resources |
It is no secret that Pharma (still) has a major diversity problem.
Brought to you by Impetus Digital
January 6, 2023 | White Papers and Resources |
A new philosophy for a new age?
Brought to you by Page & Page Health
December 13, 2022 | White Papers and Resources |
Healthcare systems around the world are already struggling to meet the demands of an ageing population, the rising incidence of chronic diseases, escalating healthcare costs …
Brought to you by Page & Page Health
December 7, 2022 | White Papers and Resources |
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study.
Brought to you by Inizio
December 7, 2022 | White Papers and Resources |
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space.
Brought to you by Inizio
December 5, 2022 | White Papers and Resources |
After more than two years of pandemic restrictions, many Pharma leaders are itching to meet with their key opinion leaders (KOLs) face-to-face again, believing that’s …
Brought to you by Impetus Digital